Code Biotherapeutics Email Format
Biotechnology ResearchPennsylvania, United States11-50 Employees
Code Biotherapeutics is a small to mid-sized biotechnology company based in Hatfield, Pennsylvania, pursuing precision genetic medicines. It has developed a proprietary non-viral DNA delivery platform designed to overcome common obstacles in gene therapy, such as safety concerns, dosing constraints, off-target effects, immune responses, and vector manufacturing complexity. The company’s internal pipeline focuses on multiple genetic diseases, with its most advanced work in Duchenne muscular dystrophy. It also conducts research programs aimed at diseases affecting the lungs, pancreas, and liver. A notable development in its history is a collaboration with Takeda to apply its delivery approach to rare disease programs.